182 related articles for article (PubMed ID: 10117769)
1. Multi-purpose evaluation of H2-antagonist usage.
Gianarkis D
Hosp Formul; 1992 May; 27(5):527-30, 532. PubMed ID: 10117769
[TBL] [Abstract][Full Text] [Related]
2. Clinical appropriateness, therapeutic equivalence, and cost of conversion of H2 antagonist therapy.
Kitrenos JG; Brown DR; Letting DJ; Rotella DL
Hosp Formul; 1993 Jan; 28(1):86-8, 91, 95-6. PubMed ID: 10123271
[TBL] [Abstract][Full Text] [Related]
3. Multidisciplinary education ensures successful formulary conversion.
Barfield PS; Amerson AB
Hosp Formul; 1991 Nov; 26 Suppl D():28-9. PubMed ID: 10136563
[TBL] [Abstract][Full Text] [Related]
4. Rational selection of H2-receptor antagonists for the hospital formulary. Roundtable discussion.
Keeffe EB; Harper JM; LeMay A; Sherrin TP; Siepler JK
Hosp Formul; 1991 Nov; 26 Suppl D():13-9. PubMed ID: 10136560
[No Abstract] [Full Text] [Related]
5. Formulary designation of cimetidine as the primary intravenous histamine H2-receptor antagonist.
Berkowitz HS
Am J Hosp Pharm; 1992 Jan; 49(1):134-5. PubMed ID: 1349201
[No Abstract] [Full Text] [Related]
6. Retrospective analysis of formulary restriction demonstrates significant cost savings.
Wetmore RW; Jennings RH
Hosp Formul; 1991 Nov; 26 Suppl D():30-2. PubMed ID: 10136564
[TBL] [Abstract][Full Text] [Related]
7. Criteria-based DUE aids in selection of preferred agent.
Drea EJ
Hosp Formul; 1991 Nov; 26 Suppl D():25-7. PubMed ID: 10136562
[TBL] [Abstract][Full Text] [Related]
8. Antiulcer therapy: an exercise in formulary management.
Foulke GE; Siepler J
J Clin Gastroenterol; 1990; 12 Suppl 2():S64-8. PubMed ID: 1978846
[TBL] [Abstract][Full Text] [Related]
9. Strategy for developing a safe and cost-effective H2-receptor antagonist program.
Quercia RA; Chow MS; Jay GT; Quintiliani R
Hosp Formul; 1991 Nov; 26 Suppl D():20-4. PubMed ID: 10136561
[TBL] [Abstract][Full Text] [Related]
10. Use of concurrent monitoring and a preprinted note to modify prescribing of i.v. cimetidine and ranitidine in a teaching hospital.
Dannenhoffer MA; Slaughter RL; Hunt SN
Am J Hosp Pharm; 1989 Aug; 46(8):1570-5. PubMed ID: 2773962
[TBL] [Abstract][Full Text] [Related]
11. Reducing costs with formulary limitation of H2-receptor antagonists in a community hospital.
Coppola P
Hosp Pharm; 1991 Feb; 26(2):126-9, 142. PubMed ID: 10136547
[TBL] [Abstract][Full Text] [Related]
12. Use of H2-receptor antagonists in children.
Dimand RJ
DICP; 1990 Nov; 24(11 Suppl):S42-6. PubMed ID: 2270695
[TBL] [Abstract][Full Text] [Related]
13. Drug usage evaluation: H2-receptor antagonist use in 30 hospitals.
Kowalsky SF; Hamilton RA; Figge HL
Hosp Formul; 1991 Sep; 26(9):725-6, 732, 734-6 passim. PubMed ID: 10114004
[TBL] [Abstract][Full Text] [Related]
14. Implementing therapeutic interchange of intravenous famotidine for cimetidine and ranitidine.
Oh T; Franko TG
Am J Hosp Pharm; 1990 Jul; 47(7):1547-51. PubMed ID: 2114789
[TBL] [Abstract][Full Text] [Related]
15. Experience with a two-tiered therapeutic interchange policy.
Rich DS
Am J Hosp Pharm; 1989 Sep; 46(9):1792-8. PubMed ID: 2572167
[TBL] [Abstract][Full Text] [Related]
16. A comparative evaluation of cimetidine and ranitidine.
Zimmerman TW; Schenker S
Ration Drug Ther; 1985 Apr; 19(4):1-7. PubMed ID: 2932770
[No Abstract] [Full Text] [Related]
17. Tri-hospital formulary management: a joint effort to standardize therapy and reduce costs.
Kile DM; McGrath ME; Schindel LP
Hosp Formul; 1987 Feb; 22(2):176, 178, 181. PubMed ID: 10280289
[TBL] [Abstract][Full Text] [Related]
18. A pharmacoeconomic analysis of IV H2-receptor antagonist use in 40 hospitals.
Segal R; Oh T; Ben-Joseph R; Russell WL
Hosp Formul; 1994 May; 29(5):379-82, 388-91. PubMed ID: 10136601
[TBL] [Abstract][Full Text] [Related]
19. Decision analysis applied to selection of histamine H2-receptor antagonists for the formulary.
Calvo MV; Fruns I; DomÃnguez-Gil A
Am J Hosp Pharm; 1990 Sep; 47(9):2002-6. PubMed ID: 1977316
[TBL] [Abstract][Full Text] [Related]
20. P & T Committee interview: Establishing and maintaining a dynamic formulary.
Rostand S; Lazarus H
Hosp Formul; 1988 Jan; 23(1):48-53. PubMed ID: 10285373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]